13
Knowing When Knowing When to Give Up to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

Embed Size (px)

Citation preview

Page 1: Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

Knowing WhenKnowing Whento Give Upto Give Up

Sensible Evaluationin Virtual Screeningfor Drug Discovery

Gwyn SkoneStephen Cameron and Irina

Voiculescu

Page 2: Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

Virtual ScreeningVirtual Screening•Part of the Drug Discovery ‘Pipeline’

• Identify & validate target• Prepare ligand database Filter ligands to select leads• Lead result optimization• Pre-clinical testing• Clinical trials• Approval and marketing

Page 3: Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

Virtual ScreeningVirtual Screening

Page 4: Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

How is it done?How is it done?

DockTarget molecule

Set of LigandConformations

Set of Scored Poses

ScoreTarget molecule

Ligand PoseReal

Page 5: Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

How is it done?How is it done?Dock(T, Ls) =•For each ligand LLs...

•For each possible conformation...• For each considered pose...

• Calculate Score(T, L)

N

Score(T, L) = Fi(t, l)lLatoms tTatoms i=1

Page 6: Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31

-500

-325

-150

0%5%

10%15%20%25%30%35%40%45%50%

Atoms evaluated

Threshold score

Percentage of poses rejected ateach stage (atom) of scoring function

evaluation, by rejection threshold

How might we improve it?How might we improve it?•Function-Based Early Rejection

Page 7: Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31

-500

-325

-150

0%5%

10%15%20%25%30%35%40%45%50%

Atoms evaluated

Threshold score

Percentage of poses rejected ateach stage (atom) of scoring function

evaluation, by rejection thresholdwith the use of atom ordering

How might we improve it?How might we improve it?•Prioritized Atom Evaluation

Page 8: Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

How might we improve it?How might we improve it?•Red: percentage of poses abandoned;•Blue: reduction in run time.

• Dotted lines are the unordered case.Early-Rejection Effect Statistics

0%

20%

40%

60%

80%

-500

-475

-450

-425

-400

-375

-350

-325

-300

-275

-250

-225

-200

-175

-150

-125

-100-7

5-5

0-2

5N

one

Threshold Score

Aban

done

d Po

ses

/Ti

me

Impr

ovem

ent

Page 9: Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

How might we improve it?How might we improve it?•Result Quota Consideration

•Black line: run time; Bars: results by RMSD (Å):0 Blue 1 < Green 2 < Yellow 3 <

Red 4ÅQuota-Based Rejection Thresholds

(averaging 3 runs of 200 results)

0%

10%

20%

30%

40%

50%

All 6 12 18 24 30 36 42 48 54 60 66 72 78 84 90

Minimum number of generations

Resu

lts

0

1

2

3

4

5

Mean run tim

e (m

inutes)

Page 10: Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

Is there anything more Is there anything more positive?positive?•Use Quaternions to represent

rotations

Comparison of Rotation Representations

0%

10%

20%

30%

40%

50%

Euler Angles Quaternions

Resu

lts

2

4

6

8

10

12

Run time (m

inutes)

Page 11: Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

Is there anything more Is there anything more positive?positive?•Learn From Prior Experience

•Search Pose Pre-Selection

Page 12: Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

Is there anything more Is there anything more positive?positive?•Start in Likely Places

•Automatic Pocket Detection

Page 13: Knowing When to Give Up Sensible Evaluation in Virtual Screening for Drug Discovery Gwyn Skone Stephen Cameron and Irina Voiculescu

end.